It deprives congressional Democrats of the ability to take credit for Trump’s result or to look like reasonable, bipartisan people interested in collaborating with the president. And as Democratic ...

This commentary proposes a hybrid drug pricing reform model balancing most favored nation (MFN) benchmarking with domestic negotiation strategies that drive equity-focused valuation frameworks. US ...

The Trump Administration has announced its desire to impose price controls on drugs – officially called a most favored nation (MFN) policy. Essentially, the policy sets the price for the targeted ...

On December 19, 2025, the Centers for Medicare & Medicaid Services (CMS) released GLOBE (Global Benchmark for Efficient Drug Pricing Model) and GUARD (Guarding U.S. Medicare Against Rising Drug Costs) ...

Earlier this year, when the administration proposed deep cuts to the National Institutes of Health, lawmakers from both parties swiftly and rightly pushed back. Slashing medical research funding, they ...

On July 31, the Trump administration called on drug manufacturers to lower prescription drug prices in the U.S. to "most favored nation" – or MFN – pricing, the lowest cost paid for the same ...

In a new survey of health policy experts conducted by the Cornell Health Policy Center, respondents expressed uncertainty about the effects of a most favored nation (MFN) prescription drug pricing ...

The Trump administration reignited the U.S. drug pricing debate by signing a sweeping Executive Order on May 12, introducing a “Most Favored Nation” (MFN) pricing framework. This policy seeks to ...

The White House is planning to officially launch its direct-to-consumer, lower-cost drug platform TrumpRx Thursday evening, unveiling the results of President Trump’s “most favored nation” (MFN) drug ...

Most Favored Nation or "MFN" drug pricing is a policy through which prescription drug prices in the United States are aligned with the lowest prices paid for the same drugs in other developed nations.